FRANCIOSO, SIMONA
FRANCIOSO, SIMONA
A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity.
2025-01-01 Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V
A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity.
2024-01-01 Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R
A retrospective analysis of 1.011 percutaneous liver biopsies performed in patients with liver transplantation or liver disease: ultrasonography can reduce complications?
2016-01-01 Filingeri, V; Francioso, S; Sforza, D; Santopaolo, F; Oddi, F; Tisone, G
A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: The TT4 randomized trial
2014-02-01 Francioso, S; Almerighi, C; Forte, P; Bandiera, F; Nosotti, L; Lionetti, R; Taliani, G; Piras, M; Ponti, M; Parruti, G; Di Candilo, F; Gentile, S; Piccolo, P; Salso, A; Riccobelli, F; Renzi, S; Longo, M; Montalbano, M; Zaru, S; Biliotti, E; Di Masi, F; Santopaolo, F; Angelico, M
An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity
2025-01-01 Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V
Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV.
2024-01-01 Magnapera, 1a; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Salpini, R; Svicher, V
Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity.
2024-01-01 Piermatteo, 1l; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R
Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity.
2025-01-01 D’Anna, S; Piermatteo, L; Magnapera, A; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, L; Milella, M; Saracino, Al; Ciancio, Al; Silberstein, C; F, ; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R
Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity.
2024-01-01 Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Svicher, V; Salpini, R
Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir.
2024-01-01 Salpini, 1r; D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, A; Abate, Ml; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher., V
Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients
2009-09-01 Angelico, F; Francioso, S; Del Ben, M; Feole, K; Carbone, M; Pignatelli, P; Violi, F; Angelico, M
Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): longterm results from a single-center 137-patient cohort prospective study
2020-01-01 Orlacchio, A; Chegai, F; Roma, S; Merolla, S; Bosa, A; Francioso, S
Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization
2015-01-01 Orlacchio, A; Chegai, F; Merolla, S; Francioso, S; Del Giudice, C; Angelico, M; Tisone, G; Simonetti, Gme
Evaluation of liver fibrosis in cirrhotic patients: comparison between elastosonography and fibroscan
2019-01-01 Roma, S; Pace, C; Amico, A; Lenci, I; Francioso, S; Chiaramonte, C; Chegai, F; Orlacchio, A
HBsAg production from integrated HBV-DNA sustains HDV persistence in the setting of a limited or even absent HBV reservoir
2024-01-01 D’Anna, 6s; Piermatteo, L; Teti, E; Di Lorenzo, A; Brancaccio, G; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R
HBV integration can sustain intrahepatic HDV activity and can modulate HBV pathogenetic potential.
2025-01-01 D'Anna, S; Piermatteo, L; Di Lorenzo, A; Carioti, L; Brancaccio, G; Teti, E; Grossi, I; Castelli, C; Magnapera, A; Malagnino, V; Iannetta, M; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R
HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli
2023-03-01 Salpini, R; Piermatteo, L; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini Silberstein, F; Sarmati, L; V. Svicher.,
HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL
2023-01-01 R, S; Piermatteo, L; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini-Silberstein, F; Sarmati, L; Svicher, V
HDV persistence acts independently from HBV reservoir extent and is sustained by HBsAg production mainly derived from integrated HBV-DNA
2025-01-01 D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R
HDV persistence is sustained by HBsAg mainly derived from integrated HBV-DNA and is independent from the extent of HBV reservoir
2024-01-01 D'Anna, 1s; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R
| Data di pubblicazione | Titolo | Autore(i) | Tipo | File |
|---|---|---|---|---|
| 1-gen-2025 | A high degree of genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity. | Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2024 | A peculiar HBsAg isoforms composition characterizes chronic HDV coinfection respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. | Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R | Intervento a convegno | |
| 1-gen-2016 | A retrospective analysis of 1.011 percutaneous liver biopsies performed in patients with liver transplantation or liver disease: ultrasonography can reduce complications? | Filingeri, V; Francioso, S; Sforza, D; Santopaolo, F; Oddi, F; Tisone, G | Articolo su rivista | |
| 1-feb-2014 | A simple rule to personalize standard dual therapy across all genotypes in naive chronic hepatitis C patients: The TT4 randomized trial | Francioso, S; Almerighi, C; Forte, P; Bandiera, F; Nosotti, L; Lionetti, R; Taliani, G; Piras, M; Ponti, M; Parruti, G; Di Candilo, F; Gentile, S; Piccolo, P; Salso, A; Riccobelli, F; Renzi, S; Longo, M; Montalbano, M; Zaru, S; Biliotti, E; Di Masi, F; Santopaolo, F; Angelico, M | Articolo su rivista | |
| 1-gen-2025 | An increased genetic variability characterises HDV sub-genotypes 1 and can drive the selection of divergent genetic pathways modulating HDV replicative potential and cytolytic activity | Piermatteo, L; Torre, G; Carioti, L; D’Anna, S; Magnapera, A; Khan, S; Etogo, L; Bertoli, A; Paba, P; Olivero, A; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Cillo, U; Vitale, A; Brancaccio, G; Battista Gaeta, G; Ciancio, A; Ceccherini-Silberstein, F; Grelli, S; Sarmati, L; Lampertico, P; Rizzetto, M; Paolo Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV coinfection (CHD) is characterized by a different HBsAg isoforms composition respect to HBV mono-infection with higher middle- and large-HBs levels paralleling the replicative and cytolytic activity of HDV. | Magnapera, 1a; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Salpini, R; Svicher, V | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV coinfection (CHD) is characterized by a more elevated production of Middle and Large HBsAg than HBV mono-infection, that parallels HDV replicative and cytolytic activity. | Piermatteo, 1l; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R | Intervento a convegno | |
| 1-gen-2025 | Chronic HDV coinfection is characterized by a more elevated production of all three HBsAg isoforms compared to HBV mono-infection, that parallels HDV replicative and cytolytic activity. | D’Anna, S; Piermatteo, L; Magnapera, A; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, L; Milella, M; Saracino, Al; Ciancio, Al; Silberstein, C; F, ; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV coinfection is characterized by a peculiar HBsAg isoforms composition respect to HBV mono-infection, with higher middle-/large-HBs levels paralleling HDV activity. | Magnapera, A; Piermatteo, L; D’Anna, S; Olivero, A; Duca, L; Torre, G; Castelli, C; Teti, E; Di Lorenzo, A; Malagnino, V; Iannetta, M; Baiocchi, L; Francioso, S; Lenci, I; Ceccherini-Silberstein, F; Milella, M; Saracino, A; Ciancio, A; Sarmati, L; Lampertico, P; Rizzetto, M; Caviglia, G; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2024 | Chronic HDV infection is sustained by an intense HBsAg production fromintegrated HBVDNA in the setting of a limited or even absent HBV reservoir. | Salpini, 1r; D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, A; Abate, Ml; Olivero, A; Gaeta, G; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher., V | Intervento a convegno | |
| 1-set-2009 | Clinical trial: low plasma cholesterol and oxidative stress predict rapid virological response to standard therapy with peginterferon and ribavirin in HCV patients | Angelico, F; Francioso, S; Del Ben, M; Feole, K; Carbone, M; Pignatelli, P; Violi, F; Angelico, M | Articolo su rivista | |
| 1-gen-2020 | Degradable starch microspheres transarterial chemoembolization (DSMs-TACE) in patients with unresectable hepatocellular carcinoma (HCC): longterm results from a single-center 137-patient cohort prospective study | Orlacchio, A; Chegai, F; Roma, S; Merolla, S; Bosa, A; Francioso, S | Articolo su rivista | |
| 1-gen-2015 | Downstaging disease in patients with hepatocellular carcinoma outside up-to-seven criteria: Strategies using degradable starch microspheres transcatheter arterial chemo-embolization | Orlacchio, A; Chegai, F; Merolla, S; Francioso, S; Del Giudice, C; Angelico, M; Tisone, G; Simonetti, Gme | Articolo su rivista | |
| 1-gen-2019 | Evaluation of liver fibrosis in cirrhotic patients: comparison between elastosonography and fibroscan | Roma, S; Pace, C; Amico, A; Lenci, I; Francioso, S; Chiaramonte, C; Chegai, F; Orlacchio, A | Articolo su rivista | |
| 1-gen-2024 | HBsAg production from integrated HBV-DNA sustains HDV persistence in the setting of a limited or even absent HBV reservoir | D’Anna, 6s; Piermatteo, L; Teti, E; Di Lorenzo, A; Brancaccio, G; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Caviglia, Gp; Svicher, V; Salpini., R | Intervento a convegno | |
| 1-gen-2025 | HBV integration can sustain intrahepatic HDV activity and can modulate HBV pathogenetic potential. | D'Anna, S; Piermatteo, L; Di Lorenzo, A; Carioti, L; Brancaccio, G; Teti, E; Grossi, I; Castelli, C; Magnapera, A; Malagnino, V; Iannetta, M; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-mar-2023 | HDV epidemic in Central Italy is stable over the last two decades and is characterized by the circulation of multiple HDV subgenotypes 1 inducing different inflammatory stimuli | Salpini, R; Piermatteo, L; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini Silberstein, F; Sarmati, L; V. Svicher., | Intervento a convegno | |
| 1-gen-2023 | HDV INFECTION IS STABLE IN CENTRAL ITALY ACROSS THE LAST TWO DECADES AND IS CHARACTERIZED BY THE CIRCULATION OF MULTIPLE HDV SUB-GENOTYPES 1 WITH A DIFFERENT PRO-INFLAMMATORY POTENTIAL | R, S; Piermatteo, L; Torre, G; D’Anna, S; Khan, S; Duca, L; Bertoli, A; Malagnino, V; Paba, P; Ciotti, M; Lenci, I; Francioso, S; Paquazzi, C; Lichtner, M; Mastroianni, C; Santopaolo, F; De Sanctis, G; Marignani, M; Pellicelli, A; Galati, G; Moretti, A; Colucci, G; Casinelli, K; Caterini, L; Iapadre, N; Parruti, G; Vecchiet, I; Paoloni, M; Grelli, S; Ceccherini-Silberstein, F; Sarmati, L; Svicher, V | Intervento a convegno | |
| 1-gen-2025 | HDV persistence acts independently from HBV reservoir extent and is sustained by HBsAg production mainly derived from integrated HBV-DNA | D'Anna, S; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno | |
| 1-gen-2024 | HDV persistence is sustained by HBsAg mainly derived from integrated HBV-DNA and is independent from the extent of HBV reservoir | D'Anna, 1s; Piermatteo, L; Brancaccio, G; Teti, E; Di Lorenzo, A; Grossi, I; Torre, G; Malagnino, V; Iannetta, M; Ceccherini-Silberstein, F; Pasquazzi, C; Cillo, U; Vitale, A; Gringeri, E; Magrofuoco, M; Pacenti, M; Baiocchi, L; Francioso, S; Lenci, I; Koffas, A; Geretti, Am; Abate, Ml; Olivero, A; Gaeta, Gb; Sarmati, L; Rizzetto, M; Gill, U; Kennedy, P; Caviglia, Gp; Svicher, V; Salpini, R | Intervento a convegno |